122 related articles for article (PubMed ID: 28334841)
1. Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices.
Scherer JN; Fiorentin TR; Sousa TRV; Limberger RP; Pechansky F
J Anal Toxicol; 2017 Jun; 41(5):392-398. PubMed ID: 28334841
[TBL] [Abstract][Full Text] [Related]
2. Analytical reliability of four oral fluid point-of-collection testing devices for drug detection in drivers.
Scherer JN; Schuch JB; Rabelo-da-Ponte FD; Silvestrin R; Ornell R; Sousa T; Limberger RP; Pechansky F
Forensic Sci Int; 2020 Oct; 315():110434. PubMed ID: 32758788
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization-mass spectrometry (GC-PCI-MS).
Cámpora P; Bermejo AM; Tabernero MJ; Fernández P
J Anal Toxicol; 2003; 27(5):270-4. PubMed ID: 12908939
[TBL] [Abstract][Full Text] [Related]
4. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
5. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
[TBL] [Abstract][Full Text] [Related]
6. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.
Cooper G; Wilson L; Reid C; Main L; Hand C
Forensic Sci Int; 2005 Jun; 150(2-3):239-43. PubMed ID: 15944065
[TBL] [Abstract][Full Text] [Related]
8. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
Ros JJ; Pelders MG; Egberts AC
J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
[TBL] [Abstract][Full Text] [Related]
9. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Krotulski AJ; Mohr ALA; Friscia M; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Cozart microplate EIA for cocaine and metabolites in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spieher V
J Anal Toxicol; 2004 Sep; 28(6):498-503. PubMed ID: 15516303
[TBL] [Abstract][Full Text] [Related]
11. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
12. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration.
Kolbrich EA; Kim I; Barnes AJ; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
J Anal Toxicol; 2003 Oct; 27(7):407-11. PubMed ID: 14606993
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
14. Screening for drugs of abuse in hair with ion spray LC-MS-MS.
Kronstrand R; Nyström I; Strandberg J; Druid H
Forensic Sci Int; 2004 Oct; 145(2-3):183-90. PubMed ID: 15451091
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.
Pehrsson A; Blencowe T; Vimpari K; Langel K; Engblom C; Lillsunde P
J Anal Toxicol; 2011 May; 35(4):211-8. PubMed ID: 21513614
[TBL] [Abstract][Full Text] [Related]
16. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
17. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation.
Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
Drug Test Anal; 2016; 8(3-4):296-303. PubMed ID: 26968560
[TBL] [Abstract][Full Text] [Related]
18. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid.
Crooks CR; Brown S
J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
[TBL] [Abstract][Full Text] [Related]
20. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
J Forensic Sci; 2005 Jul; 50(4):928-32. PubMed ID: 16078500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
